ArticleCurrent oncology (Toronto, Ont.)2020

Nivolumab and ipilimumab immunotherapy for hemodialysis patients with advanced renal cell carcinoma.

Y Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.